Susquehanna International Group
VIVO

Susquehanna International Group’s Meridian Bioscience Inc VIVO Stock Holding History

Susquehanna International Group’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-17,800
Closed -$591K – 14174
2022
Q4 		$591K Sell
17,800
-5,900
-25% -$190K ﹤0.01% 7414
2022
Q3 		$747K Buy
23,700
+1,900
+9% +$61.5K ﹤0.01% 7396
2022
Q2 		$663K Sell
21,800
-15,800
-42% -$427K ﹤0.01% 7580
2022
Q1 		$976K Sell
37,600
-102,000
-73% -$2.43M ﹤0.01% 7186
2021
Q4 		$2.85M Sell
139,600
-157,600
-53% -$3.02M ﹤0.01% 4745
2021
Q3 		$5.72M Buy
297,200
+2,900
+1% +$57.8K ﹤0.01% 3711
2021
Q2 		$6.53M Buy
294,300
+25,400
+9% +$539K ﹤0.01% 3550
2021
Q1 		$7.06M Buy
268,900
+205,800
+326% +$4.89M ﹤0.01% 3334
2020
Q4 		$1.18M Sell
63,100
-10,500
-14% -$196K ﹤0.01% 6331
2020
Q3 		$1.25M Buy
73,600
+47,500
+182% +$923K ﹤0.01% 5585
2020
Q2 		$608K Sell
26,100
-20,000
-43% -$290K ﹤0.01% 6956
2020
Q1 		$387K Buy
46,100
+29,100
+171% +$245K ﹤0.01% 7478
2019
Q4 		$166K Buy
+17,000
New +$160K ﹤0.01% 8886
2019
Q3 		– Sell
-19,000
Closed -$226K – 11052
2019
Q2 		$226K Buy
+19,000
New +$229K ﹤0.01% 8893
2018
Q4 		– Sell
-11,200
Closed -$167K – 10278
2018
Q3 		$167K Sell
11,200
-5,400
-33% -$83.7K ﹤0.01% 8351
2018
Q2 		$264K Buy
+16,600
New +$248K ﹤0.01% 8099
2017
Q4 		– Sell
-10,700
Closed -$153K – 10110
2017
Q3 		$153K Sell
10,700
-15,600
-59% -$223K ﹤0.01% 8177
2017
Q2 		$414K Sell
26,300
-15,000
-36% -$216K ﹤0.01% 6990
2017
Q1 		$570K Sell
41,300
-3,700
-8% -$51.7K ﹤0.01% 6259
2016
Q4 		$797K Sell
45,000
-25,000
-36% -$439K ﹤0.01% 6005
2016
Q3 		$1.35M Buy
70,000
+13,800
+25% +$270K ﹤0.01% 4242
2016
Q2 		$1.1M Buy
56,200
+25,700
+84% +$504K ﹤0.01% 4701
2016
Q1 		$629K Sell
30,500
-5,400
-15% -$106K ﹤0.01% 5991
2015
Q4 		$737K Buy
35,900
+2,000
+6% +$38.3K ﹤0.01% 6033
2015
Q3 		$580K Buy
33,900
+11,100
+49% +$203K ﹤0.01% 6838
2015
Q2 		$425K Sell
22,800
-22,100
-49% -$410K ﹤0.01% 7936
2015
Q1 		$857K Sell
44,900
-12,300
-22% -$227K ﹤0.01% 6070
2014
Q4 		$942K Sell
57,200
-22,500
-28% -$386K ﹤0.01% 5995
2014
Q3 		$1.41M Buy
79,700
+41,800
+110% +$821K ﹤0.01% 5260
2014
Q2 		$782K Buy
37,900
+17,900
+90% +$368K ﹤0.01% 6579
2014
Q1 		$436K Buy
20,000
+10,600
+113% +$243K ﹤0.01% 6961
2013
Q4 		$249K Buy
+9,400
New +$231K ﹤0.01% 7896

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Susquehanna International Group's VIVO Position: Q1 2023 in Review

Susquehanna International Group sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 18,318 shares — an estimated $608K sold.

Susquehanna International Group first reported a position in VIVO in Q4 2013 and held it in 24 quarters. The position peaked at $3.09M in Q2 2021. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Susquehanna International Group reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Susquehanna International Group sold 18,318 Meridian Bioscience Inc shares in Q1 2023, an estimated $608K.
  • Susquehanna International Group first reported a position in Meridian Bioscience Inc in Q4 2013 and held it in 24 quarters.
  • Susquehanna International Group's Meridian Bioscience Inc position peaked at $3.09M in Q2 2021.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.